Advanced Search

Oncology & Hematology Coding Alert

Reader Question:

86386 Offers NMP22 Reporting Options

Published on Thu Sep 13, 2012

Question: We're a CLIA-waived lab performing the NMP22 test by Alere. How should we report the test?Tennessee SubscriberAnswer: The CPT® 2012 code for nuclear matrix protein 22 (NMP22) is 86386 (Nuclear Matrix Protein 22 [NMP22], qualitative), but that's not the entire answer to your question.Because you're a lab operating with waived status under the Clinical Laboratory Improvement Amendments (CLIA), you can perform and report only those tests that are granted waived status. When you report a waived test, you need to append modifier QW (CLIA waived test) to the lab test code.You'll find that the CLIA-waived test list, effective April 1, 2012, does include 86386-QW. The effective date of the waived status for the code is Jan. 1, 2012. You can see the list at www.cms.gov/Regulations-and-Guidance/Legislation/CLIA/downloads/waivetbl.pdf. The test: As the CLIA-waived test list states, the test is an Immunoassay for the qualitative detection of nuclear matrix protein NMP22 in urine [...]
You’ve reached your limit of free articles. Already a subscriber? Log in.
Not a subscriber? Subscribe today to continue reading this article. Plus, you’ll get:
  • Simple explanations of current healthcare regulations and payer programs
  • Real-world reporting scenarios solved by our expert coders
  • Industry news, such as MAC and RAC activities, the OIG Work Plan, and CERT reports
  • Instant access to every article ever published in your eNewsletter
  • 6 annual AAPC-approved CEUs*
  • The latest updates for CPT®, ICD-10-CM, HCPCS Level II, NCCI edits, modifiers, compliance, technology, practice management, and more
*CEUs available with select eNewsletters.

Other Articles in this issue of

Oncology & Hematology Coding Alert

View All